Abbvie Header week 48

Abbvie Header week 48

X

Digital content for AbbVie Contract Manufacturing

ABBVIE CONTRACT MANUFACTURING

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2022, Corporate Presentation, Hot Melt Extrusion, Microbial Fermentation Services, Potent API and Drug Product, Oral Solid Dose, Biologics Development & Manufacturing, Antibody Drug Conjugates (ADC), GMP Certificate 2020, Fill-Finish: PreFilled Syringe, The AbbVie Code of Business Conduct, Our Impact 2019, AbbVie Global Supply Chain Management

VIDEO(s)

Corporate Video, Biologics Ballytivnan, Bioresearch Center Overview, Filling Suite, Harvest Setup, Logistics: Shipping Bottles, Microbiology Testing, POD Filter Disassembly, Water for Injection (WFI) Still, Weigh/Dispense, Introducing AbbVie, Our Principles, We are AbbVie

DIGITAL CONTENT

1 Supplier Blog, 40 News

APIs // Active Pharmaceutical Ingredients

23 APIs, 17 USDMF, 8 CEP/COS, 4 KDMF, 5 NDC API, 8 Listed APIs

DEVELOPMENTS

231 Drug(s) in Development

231 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

967 Dossiers, 412 FDA Orange Book, 170 Europe, 114 Canada, 204 Australia, 67 South Africa

SERVICES

All Services, API Manufacturing, Drug Product Manufacturing, API & Drug Product Development, Packaging

KEY SERVICES

Ophthalmic Solution Manufacturing, Sterile Fill and Finish for Parenterals, Prefilled Syringe Contract Manufacturing, Ophthalmic Formulation Development, Parenteral Formulation Development, Development of Topical Creams and Gels, Topical Formulation Development

Ophthalmic Solution Manufacturing
Sterile Fill and Finish for Parenterals
Prefilled Syringe Contract Manufacturing
Ophthalmic Formulation Development
Parenteral Formulation Development
Development of Topical Creams and Gels
Topical Formulation Development

INSPECTIONS & REGISTRATIONS

111 FDA, 41 EDQM, 3 GDUFA

Full View Screen

Full Screen View

Ophthalmic Dealmakers: Novartis, AbbVie forge deals to develop ocular gene therapies

Excel-Download

Ophthalmic Dealmakers: Novartis, AbbVie forge deals to develop ocular gene therapies

Impressions: 4062

During the Covid-19 pandemic and the concomitant lockdowns, people may have found it difficult to visit eye clinics or hospitals, but globally, ophthalmology has been witnessing a healthy growth. Several factors are contributing to this growth, su...

#PharmaFlow by PHARMACOMPASS

31 Mar 2022

Contact Supplier

View Presentation

AbbVie Contract Manufacturing 250

CPhI South East Asia Virtual

Not Confirmed

envelop Contact Supplier

Market Place

Home

Menu

Post Enquiry

Market Place

Search